Funding for this research was provided by:
Guangxi Key Research and Development Program (2021AB12032)
Received: 18 May 2022
Accepted: 30 November 2022
First Online: 7 December 2022
: The study was approved by the Medical Ethics Committee of Guangxi Chest Hospital (ethical approval number: 2022-011). Available routine clinical and treatment data were used anonymously and extracted from electronic medical records. In addition, all methods in this study were performed following the approved guidelines. Given the retrospective nature of the study, the need for informed consent was waived after review by the Medical Ethics Committee of the Guangxi Chest Hospital. All patient information was desensitized and no patient privacy was disclosed during the study.
: Not applicable.
: The authors declare that they have no financial competing interests.